Brady hurt by acquisition costs

Commodity software solutions provider Brady reported a sharp drop in annual pre-tax profit, following acquisition costs, but said trading to date remains in line with the board's expectations.

Commodity software solutions provider Brady reported a sharp drop in annual pre-tax profit, following acquisition costs, but said trading to date remains in line with the board's expectations.

Brady, which operates in the metals, energy, recycling and soft commodities markets, said it was pleased with its progress in 2012 after 20 significant new licence contracts, a number of installations and upgrades and three new acquisitions.

"The board believes that the group is well placed to deliver further momentum in growth during 2013 and beyond," it said in a statement.

Although there are still concerns about the economic outlook for 2013, Brady said it is optimistic of growth in its underlying markets.

"The group now has a much larger client base, stronger cross-product offering and wider geographic reach in order to take advantage of this opportunity. Brady is seeing the benefits of increased scale and reach," it added.

Total revenue for year ended December 31st 2012 jumped 47% to £28.14m from the same time a year earlier. Pre-tax profit fell to £804,000 during the period from £2.1m the year before.

A dividend of 1.50p has been offered, up 7% from the year earlier.

Looking ahead, the group said now that the two recently acquired businesses have been integrated within Brady Energy, the group expects the year to be very busy.

"We are encouraged by an advanced pipeline which, in monetary terms increased during 2012 and further in early 2013."

CJ

Recommended

Imperial Brands has an 8.3% yield – but what’s the catch?
Share tips

Imperial Brands has an 8.3% yield – but what’s the catch?

Tobacco company Imperial Brands boasts an impressive dividend yield, and the shares look cheap. But investors should beware, says Rupert Hargreaves. H…
20 May 2022
Investing in drugmakers: uncommon profits from curing rare diseases
Share tips

Investing in drugmakers: uncommon profits from curing rare diseases

Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors becaus…
20 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022
Delivering profits: should you buy Royal Mail shares?
Share tips

Delivering profits: should you buy Royal Mail shares?

The volume of parcels delivered by Royal Mail soared during the pandemic, and so did its profits. But it has been coming under pressure lately. So, as…
19 May 2022

Most Popular

Barry Norris: we’re already in the 1970s. Here’s how to invest
Investment strategy

Barry Norris: we’re already in the 1970s. Here’s how to invest

Merryn talks to Barry Norris of Argonaut capital about the parallels between now and the 1970s; the transition to “green” energy; and the one sector w…
19 May 2022
The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves looks at the FTSE 100’s top yielding stocks for income investors to consider.
18 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022